drugset / Trial / NCT00922714
Scandinavian Intensive Care Unit (ICU) Glutamine Study
RandomizedSingle-groupDouble-blindTreatment
Summary
This is a prospective double-blinded placebo-controlled block randomized study in intensive care patients comparing intravenous glutamine supplementation to placebo. The hypothesis is an improvement of clinical outcome. The primary endpoint is a reduction in the Sequential Organ Failure Assessment (SOFA) score on day 7 of treatment.
Timeline
- Start
- 2003-10
- Primary completion
- 2007-05
- Completion
- 2009-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glutamine | Other / unclassified | 0.285 g/kg | Intravenous |
Indications
No indication recorded.